Biodistribution of Post-Therapeutic Versus Diagnostic 131I-MIBG Scans in Children with Neuroblastoma

Pediatric Blood and Cancer

Volumn 42, Issue 3, 2004, Pages 268-274

  Hickeson, Marc P ^a   Charron, Martin ^a   Maris, John M ^a   Brophy, Patricia ^a   Kang, Tammy I ^a   Zhuang, Hongming ^a   Khan, Jehanzeb ^a   Nevrotski, Teresa ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Biodistribution; Iodobenzylguanidine; Metastases; Neuroblastoma; Neuroblastoma diagnosis; Neuroblastoma therapy

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 131; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADOLESCENT; ADRENAL GLAND; ADULT; ARTICLE; BLADDER; BRAIN METASTASIS; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG DISTRIBUTION; FEMALE; HEART; HUMAN; IMAGE ANALYSIS; INCISION; INFANT; INTERMETHOD COMPARISON; INTESTINE; KIDNEY; LUNG; MALE; METASTASIS; NEUROBLASTOMA; NOSE MUCOSA; PATHOLOGY; PATIENT SELECTION; PHEOCHROMOCYTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE DISTRIBUTION; RETROSPECTIVE STUDY; SALIVARY GLAND; SCINTISCANNING; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SPLEEN; THORAX; THYROID GLAND; TISSUE DISTRIBUTION;

EID: 1242272106     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10454     Document Type: Article

References (36)

1. Young JL, Riesl LG, Silverberg E, et al. Cancer incidence, survival, and mortality for children under 15 years of age. Cancer 1986; 58:598-602.
2. Shulkin BL, Shapiro B. Current concepts on diagnostic use of MIBG in children. J Nucl Med 1998;39:679-688.
3. Pizzo PA, Poplack DG, Morowitx ME, et al. Solid tumors of childhood. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and practice of oncology. 4th edn. Philadelphia, PA: Lippincott; 1993. pp 1738-1791.
4. 131I MIBG therapy in neuroblastoma: Mechanisms, rationale, and current status. Med Pediatr Oncol 1999; 32:427-431.
5. 131I-meta-iodo-benzylguanetidine, high dose chemotherapy, and immunotherapy. A pilot study. Eur J Cancer 1998; 34:1398-1402.
6. 131I-MIBG in neuroblastoma: A phase II study in nine patients. Med Pediatr Oncol 1987;15:205-211.
7. 131I-MIBG therapy of neuroblastoma at diagnosis ("MIBG de novo"). J Nucl Biol Med 1991;35:248-251.
8. Treuner J, Gerein V, Klingebiele T, et al. MIBG treatment in neuroblastoma; experiences of the Tuebingen/Frankfort group. Prog Clin Biol Res 1988;271:669-678.
9. 131I-metaiodobenzylguanedine in the treatment of neuroblastoma. Med Pediatr Oncol 1998;31:22-26.
10. Goldberg SS, Desantes K, Huberty JP, et al. Engraftment after myeloablative doses of 131-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma. Med Pediatr Oncol 1998;30:339-346.
11. 131I] metaiodobenzylguanidine, high dose melphalan, and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastoma. Eur J Cancer 1995;31:252-256.
12. Meller S. Targeted radiotherapy for neuroblastoma. Arch Dis Child 1997;77:389-391.
13. 131I metaiodobenzylguanidine in the treatment of neural crest tumors. J Nucl Biol Med 1991;35:177-362.
14. Giammante F, Lumbroso J, Richard N, et al. Radioiodinated metaiodobenzylgauanidine in neuroblastoma: Influence of high dose on tumour site detection. Eur J Nucl Med 1995;22:1180-1183.
15. Parisi MT, Matthay KK, Huberty JP, et al. Neuroblastoma dose-related sensitivity of MIBG scanning. Radiology 1992;184:463-467.
16. Fatourechi V, Hay ID, Mullan BP, et al. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer? Thyroid 2000;10:573-577.
17. Sisson JC, Wieland DM, Sherman P, et al. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620-1624.
18. Iavarone A, Lasorella A, Servidir T, et al. Uptake and storage of MIBG are frequent neural functions of human neuroblastoma cell lines. Cancer Res 1993;53:304-309.
19. Harttner RS, Pounds TR, Matthay KR. Normal cerebellar MIBG localization implications in the interpretation of delayed scans. Clin Nucl Med 1994;19:985-988.
20. Bonnin F, Lumbroso J, Tenenbaum F, et al. Refining interpretation of MIBG scan in children. J Nucl Med 1994;35:803-810.
21. Preisman R, Halpein S. Detection of metastatic thyroid carcinoma after the administration of a therapeutic dose of 131-iodine. Eur J Nucl Med 1978;3:69-70.
22. Pacini F, Lippi F, Fomina N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28:1888-1891.
23. Bonnin F, Lumbroso J, Tenenbaum F, et al. Detection and treatment of lung metastases in patients with normal chest X-rays. J Nucl Med 1988;29:1790-1794.
24. 131I-MIBG) in man: Evaluation by scintigraphy. J Nucl Med 1983;24:672-682.
25. Feldman JM, Blinder PA, Lucas KJ, et al. I-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors. J Nucl Med 1986;27: 1691-1696.
26. Von Moll L, McEwan AJ, Shapiro B, et al. MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J Nucl Med 1987;28:979-988.
27. Geatti O, Shapiro B, Barillari B. Scintigraphic depicting on an insulinoma by I-131 metaiodobenzylguanidine. Clin Nucl Med 1989;14:903-905.
28. Kaltsas G, Korbonits M, Heintz E, et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and the localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 2001;86:895-902.
29. Castagnoli A, Biti G, DeCristofaro MT, et al. Merkel cell carcinoma and iodine-131 metaiodobenzylguanidine scan. Eur J Nucl Med 1992;19:913-916.
30. Rainis T, Ben-Haum S, Dickstein G. False-positive metaiodobenzylguanidine in a patient with a huge adrecortical carcinoma. J Clin Endocrinol Metab 2000;85:5-7.
31. Letizia C, Detoma G, Massa R, et al. False-positive diagnosis of adrenal pheochromocytoma on iodine-123 MIBG scan. J Clin Endocrinol Metab 1998;21:779-783.
32. 131I-metaiodobenzylguanidine (mIBG) for bronchial oat cell cancer and melanoma detection. Eur J Nucl Med 1989;15:629-631.
33. Wadler S, Tai K, Cherviu LR, et al. Iodine-131 MIBG scintigraphy in small cell lung cancer. Eur J Nucl Med 1989;15:108-110.
34. Hayward RS, Bowering CK, Warshawski RS. I-131 metaiodobenzylguanidine uptake in a parathyroid adenoma. Clin Nucl Med 1988;13:632-634.
35. Biasotti S, Garaventa A, Villavecchia GP, et al. False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma. Med Pediatr Oncol 2000;25:153-155.
36. Heyman S, Evan AE, D'Angio GJ. I-131 metaiodobenzylguanidine: Diagnostic use in neuroblastoma patients in relapse. Med Pediatr Oncol 1988;16:337-340.